Use of chlortetracycline for treatment of new feedlot cattle.
Two 56-d shipping fever trials of similar design were conducted the same season (fall) at Kansas State University (KSU) and at Purdue University (PU) to compare various levels of chlortetracycline (0 or 350 mg X head-1 X d-1 continuously or 1, 2 or 4 g X head-1 X d-1 for the first 14 d). Weanling crossbred steer calves were utilized (210 head of Angus X Simmental, averaging 197 kg, at KSU; 268 head of Angus X Hereford, averaging 192 kg, at PU). For the first 28 d in the KSU trial (October 13 to December 8), cattle that received 4 g X head-1 X d-1 the first 14 d gained more rapidly (P less than .05) than cattle fed 350 mg X head-1 X d-1 continuously or than the controls that received no chlortetracycline (CTC; 1.05 vs .92 or .93 kg/d, respectively). Cattle that received 4 g CTC X head-1 X d-1 for the first 14 d required less (P less than .05) dry matter per kg gain than steers that received 350 mg X head-1 X d-1 continuously over the 56-d period. In the PU trial (October 6 through December 1), all CTC treatments resulted in increased feed efficiency (P less than .05) over the controls through 28 d, and the 4 g X head-1 d-1 for 14 d and 350 mg X head-1 X d-1 continuously, improved feed efficiency over the other groups for the 56-d period.(ABSTRACT TRUNCATED AT 250 WORDS)
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy* / Q000517:prevention & control; D002751:Chlortetracycline / Q000627:therapeutic use*; D008297:Male; D010326:Pasteurella Infections / Q000188:drug therapy*; D012766:Pasteurellosis, Pneumonic / Q000188:drug therapy* / Q000517:prevention & control
D002751:Chlortetracycline